Abstract
The amyloid-β protein precursor (AβPP) is cleaved by a transmembrane protease termed β-site AβPP cleavage enzyme (BACE1), which is being explored as a target for therapy and prevention of Alzheimer’s disease (AD). Although genetic deletion of BACE1 results in abolished amyloid pathology in AD model mice, it also results in neurodevelopmental phenotypes such as hypomyelination and synaptic loss, observed in schizophrenia and autism-like phenotype. These lines of evidence indicate that the inhibition of BACE1 causes adverse side effects during the neurodevelopmental stage. However, the effects of the inhibition of BACE1 activity on already developed neurons remain unclear. Here, we utilized hippocampal slice cultures as an ex vivo model that enabled continuous and long-term analysis for the effect of BACE1 inhibition on neuronal circuits and synapses. Temporal changes in synaptic proteins in hippocampal slices indicated acute synaptic loss, followed by synapse formation and maintenance phases. Long-term BACE1 inhibition in the neurodevelopmental stage caused the loss of synaptic proteins but failed to alter synaptic proteins in the already developed maintenance stage. These data indicate that BACE1 function on synapses is dependent on synaptic developmental stages, and our study provides a useful model to observe the long-term effect of BACE1 activity in the brain, and to evaluate adverse effects of BACE inhibitors.
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder and the most common cause of dementia in the elderly. An excessive accumulation of amyloid-β peptide (Aβ), derived from amyloid-β protein precursor (AβPP), results in aggregation and amyloid deposition in the brains of AD patients [1]. AβPP is sequentially cleaved by two membrane-bound aspartic proteases called β- and γ-secretase. The major β-secretase is the type 1 transmembrane protein termed BACE1 (β-site AβPP cleaving enzyme 1), and γ-secretase is a complex, which is composed from four types of membranespanning proteins [2]. Although both enzymes are considered to be therapeutic targets for AD, genetic deletion of the γ-secretase catalytic component, presenilin-1, showed severe neuronal and skeletal developmental deficits and resulted in embryonic lethality [3, 4].
BACE1 is the rate-limiting enzyme involved in AβPP cleavage at the N-terminal of Aβ [5, 6]. Interactions between AβPP and BACE1 are regulated by switching AβPP’s association with distinct microdomains. Neuronal hyperactivity causes a shift of AβPP to BACE1-containing microdomains and induces β cleavage [7]. BACE1 functions in the synapse through processing substrates such as AβPP-like proteins (APLP) [8], neuregulin [9], and β2 and β4 subunits of voltage-gated Na+ channels [10, 11] are under investigation. BACE1 knockout mice showed diminished Aβ depositions in AD model mice, and in contrast to γ-secretase, an apparent phenotype was not observed [12]. Moreover, in AD, BACE1 expression and activity are increased in brain regions affected by amyloid deposition [13], suggesting a pathogenic function of BACE1. These lines of evidence indicate BACE1 as a promising therapeutic target for AD. However, recent research reported that BACE1 knockout mice show hypomyelination and failure of synaptic development, which together result in complex neurodevelopmental phenotypes similar to schizophrenia and autism [14]. Although these data indicated that BACE1 has a significant role in neurodevelopment, BACE1 functions in developed neurons and synapses are still largely unknown. Accordingly, an effective model that enables continuous and chronic monitoring of BACE1 activity and its inhibitors’ effects at various neurodevelopmental stages is required to develop BACE1-based AD therapy.
Although cultured cell line model-based assays have been used to reveal molecular mechanisms of AβPP and BACE1, primary cultured neurons that are morphologically and functionally specialized have an advantage as an in vivo platform to investigate AD mechanisms. Neuronal/synaptic activity is known as an important regulator of β cleavage of AβPP [7, 15].AβPP is anterogradely transported in axons and may contribute to neurite outgrowth and synaptogenesis in neurons [16]. A recent study showed that approximation and trafficking of AβPP and BACE1 in cultured hippocampal neurons, using optical assay, based on fluorescence complementation [17]. Dissociated cultures, however, have disadvantages; they have lost the tissue architecture of the brain. Neural circuits, glial cells, and the extracellular matrix are important for Aβ production, degradation, and accumulation. Furthermore, recent studies indicated that synaptic activity and the default mode network of the brain affect BACE1 activity and AβPP processing [18]. Although experiments in animal models provide important information on the development of AD-like pathologies and physiology of related molecules [19], they require lengthy animal experiments and laborious monitoring of multiple parameters following manipulations. In addition, mouse genetic model phenotypes might be affected by compensatory alterations and developmental changes.
Organotypic brain slice culture methods are used in central nervous system research because they have advantages over both in vivo and in vitro platforms [20]. Prepared slice cultures preserve tissue structures, maintain neural circuit and synapse properties, and replicate the native status of the in vivo context. Slice cultures from hippocampi are widely used to investigate the effect of drugs and gene manipulation on neurons and glia [21, 22]. These preparations are amenable to physiological, pharmacological, and morphological examinations for a long period. In hippocampal slice cultures, development of synaptic transmission and ultrastructure was documented as in the in vivo situation [23, 24]. We previously showed that hippocampal slice cultures maintained intrinsic neural circuit and synaptic plasticity, long-term potentiation (LTP), and long-term depression (LTD) [25, 26]. The hippocampus is thought to be one of the first regions of the brain to suffer damage in AD [27].
In this study, we investigated the physiology of BACE1 and AβPP processing using organotypic hippocampal slice cultures. Our analysis clearly showed that hippocampal slice cultures are suitable for continuous investigation of BACE1 activity for a long period. We further showed that our system enabled functional dissections of BACE1 activity in developing and developed neurons. Our established ex vivo model system will facilitate understanding of the function of secretase activity and development of therapies for AD.
MATERIALS AND METHODS
Hippocampal slice culture
The experiments in this study were approved by the committees on animal experiments of Juntendo University. Animals were purchased from Nihon SLC (Hamamatsu, Japan) and treated according to our institutional guidelines. Rat hippocampal slice cultures were prepared following conventional methodology [26, 28]. Briefly, whole brains were excised from anaesthetized Sprague-Dawley rats at postnatal day 7–8 and the hippocampi were isolated. Slices of 400-μm thickness were obtained from the central region of the hippocampi, using a tissue chopper (McIllwain). The slices were placed on a polytetrafluoroethylene membrane filter (Millicell-CM; Millipore, Carrigtwohill, Ireland), and culture medium (see below for composition) was added up to the bottom surface of the filter. These prepared cultures were maintained at 37°C with 5% CO2-enriched humidified atmosphere (Fig. 1B, C). The slice culture medium (SCM) contained 50% minimal essential medium based on Hanks’ salts (Nacalai, Kyoto, Japan), 25% Hank’s balanced salt solution (Nacalai), and 25% heat-inactivated horse serum (Life Technologies, Gaithersburg, MD). The culture medium was replaced twice a week with fresh medium during the entire culture period.
Drug application
Test drugs were dissolved into water to concentrations 1000 times higher than the final levels, kept at 4 or –20°C until use, and diluted into medium unless otherwise stated. The α-secretase inhibitor TAPI-1(tumor necrosis factor-α processing inhibitor-1) and BACE inhibitor (β-secretase inhibitor IV) (Millipore) were dissolved into DMSO (Sigma-Aldrich, MI, USA) to concentrations of 500 and 1000 times higher than the final levels, respectively, and kept at –20°C until use. TAPI-1 and BACE1 were added to fresh SCM before analysis.
Immunohistochemical staining
For the immunohistochemical staining of presynaptic structures, the cultured slices were fixed with 4% paraformaldehyde in phosphate-buffer for 1 h at 4°C. The fixed preparations were rinsed with phosphate-buffered saline (PBS) and then treated with PBS containing 0.1% Triton X-100 and 5% fetal bovine or horse serum at 24°C for 30 min. The treated slices were incubated with a primary antibody against NeuN (a marker protein for neuronal nuclei; mouse monoclonal, 1:200 dilution, 24 h, 4°C; Chemicon, Temecula, CA, USA), synaptophysin (a marker protein for presynapses; mouse monoclonal, 1:200 dilution, Millipore), PSD95 (a marker protein for postsynapses; monoclonal, 1:200 dilution, Sigma-Aldrich), MAP2 (Microtubule-associated protein 2; monoclonal 1:200 dilution, Abcam), Neurofilament 200 (a marker protein for axon; monoclonal 1:200 dilution, Sigma-Aldrich), and BACE1 (rabbit monoclonal, D10E5, 1:100 dilution, 24 h, 4°C; Cell signaling Technology, Danvers, MA, USA). The primary antibody-treated slices were incubated with a secondary antibody conjugated with Alexa Fluor 488 or 594 at 24°C temperature for 2–2.5 h. The slices were examined using a Leica SP5/TCS confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany) or an Olympus IX71 (Olympus, Tokyo, Japan) with Orca-ER cooled CCD camera (Hamamatsu Photonics, Hamamatsu, Japan).
Electrophoresis and immunoblotting
Acute or cultured hippocampal slices were solubilized in ice-cold RIPA buffer [1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 25 mM Tris-HCl, pH 7.5, 137 mM NaCl, and 3 mM KCl with a protease inhibitor cocktail (Complete, Roche Diagnostics, Mannheim, Germany)]. Samples were resolved by SDS-PAGE and transferred onto polyvinylidene fluoride membranes (Immobilon-P, Millipore). Membranes were incubated in 5% skim milk in TBST (1× Tris-buffered saline with 0.1% Tween 20) at 25°C for 30–60 min to block nonspecific binding. Membranes were incubated at 4°C overnight or 25°C for 2 h with primary antibodies: anti-synaptophysin (guinea pig, 1:2000 dilution; Frontier Institute, Hokkaido, Japan, or mouse monoclonal, 1:200 dilution, Millipore), anti-PSD95 (mouse monoclonal, 1:3000 dilution, Sigma-Aldrich), anti-BACE1 (rabbit monoclonal, D10E5, 1:2000 dilution; Cell signaling Technology), anti-AβPP (mouse monoclonal, 22C11, 1:1000 dilution; Millipore, or rabbit, AβPP-C15 1:1000 dilution [7]), anti-phospho AβPP (Thr668) (rabbit, 1:1000 dilution, Cell Signaling), anti-βIII tubulin (mouse monoclonal, TuJ-1, 1:5000 dilution; R&D systems Minneapolis, MN, USA), or anti-β-actin (a loading control, mouse monoclonal, 1:5000 dilution; Wako Chemicals, Osaka, Japan). AβPP-C15 antibody was raised against C-terminal 12-aa peptide of AβPP, and adsorbed against corresponding C-terminal peptides of APLP1 and APLP2. After four changes of 1× TBST and three 5-min washes at 25°C, membranes were incubated in horseradish peroxidase-conjugated secondary antibodies. After four washes at 25°C, membranes were incubated with ECL solution (Thermo Fisher Scientific, MA, USA). For quantification, chemiluminescence light signals in Super Signal Dura substrate (Thermo Fisher Scientific) were captured by a cooled charge-coupled device camera system (LAS-3000plus; Fuji Film, Japan) that ensured wide ranges of linearity. Densitometric quantification of synaptic protein expression in culture slices were normalized to β-actin or βIII tubulin. The protein content was estimated using bicinchoninic acid (BCA) reagent (Thermo Fisher Scientific).
Amyloid-β assay and sAβPPβ assay
The levels of Aβ40 and Aβ42 were measured using a solid phase by sandwich ELISA kit following the supplier’s information (IBL, Gunma, Japan). The test samples and standards were added to the 96-well plate (precoated with anti-Aβ (35–40) (1A10) mouse IgG for Aβ40, precoated with anti-Aβ (38–42) rabbit IgG for Aβ42) and incubated overnight at 4°C. After several washes with EIA wash buffer, 100 μL of HRP-labeled anti-mouse/rat Aβ (1–16) rabbit IgG solution was added to each well (except for the wells corresponding to reagent blanks) and incubated at 4°C for 1 h. After a thorough wash, 100 μL of tetramethylbenzidine solution was added to each well and incubated in the dark at 24°C for 30 min. The reaction was stopped by adding 100 μL of 1 N sulfuric acid, and the readings were taken at 450 nm. The levels of Aβ in the test samples were calculated by incorporating the unknown values into the standard curve obtained in the assay. The levels of soluble AβPP β (sAβPPβ) were measured using the IBL assay kit (IBL, 96 well plate precoated with anti-sAβPPβ rabbit IgG, HRP-labeled anti-AβPP18 mouse IgG) as described above.
Propidium iodide staining
Propidium iodide (PI; Nacalai) is a red-fluorescent nuclear and chromosome counterstain. Since livecells are not permeable to PI, it is commonly used to detect dead cells in a population. We used PI fluorescence intensity as an index of total neuronal degeneration. Cultured slices were exposed to SCM containing 10 μg/mL PI for 12 h. The whole slice was photographed with identical incident light intensity and exposure time on the fluorescence microscope (IX70 with a 4x objective lens, Olympus). PI fluorescence intensity was measured on all micrographs using MetaMorph software (Molecular Devices, CA, USA).
Electrophysiology
Extracellular recording of field excitatory postsynaptic potential (fEPSP) was performed in a conventional manner [26]. Briefly, a glass microcapillary electrode for recording (3 M NaCl or artificial cerebrospinal fluid (aCSF); see below, 3–16 MΩ; input resistance) was placed in the CA1 stratum pyramidale. For evoking synaptic responses, a bipolar tungsten stimulating electrode was placed in the CA3 stratum pyramidale, and a pulse of 100 μs was delivered once in 30 s. An Axopatch 1D amplifier (Axon Instruments) was used, and the signal was filtered at 1 kHz, digitized at 10 kHz, and stored on a personal computer (pClamp 10, Molecular Devices). Input-output curves were collected by varying the stimulation strength applied in the range 100–400 μA. D-2-amino-5-phosphonovaleric acid (D-APV; 25 μM) was applied to prevent NMDA receptor-mediated synaptic responses. The composition of the aCSF was (mM) 126 NaCl, 5 KCl, 1.25 NaH2PO4, 2.5 CaCl2, 2 MgSO4, 22 NaHCO3, and 10 glucose. This aCSF was equilibrated with 95% O2 and 5% CO2 by constant bubbling. Experiments were performed at 32±1°C.
Statistical analysis
All quantitative data were presented as mean±standard deviation (SD) or standard error of the mean (SEM). Statistical analysis was performed using either Student’s t-test (two-group comparison) or ANOVA (more than two groups) followed by post hoc comparison. The level of significance was indicated by asterisks: *p < 0.05, **p < 0.01, ***p < 0.001
RESULTS
Preparation of rat hippocampal slice culture
First, to evaluate the BACE1 activity and its role in neural tissue consecutively, we assessed organotypic hippocampal slice cultures by immunohistochemistry. We have previously reported that cultured rat hippocampal slices retained neuronal activity for several weeks [25, 29]. Immunofluorescent staining with antibodies against NeuN, a neuronal nuclear protein used as a neuron-specific marker [30], showed that gross patterns of neuron arrangement were preserved for 40 days in vitro (DIV) (Fig. 1A). Next, we stained cultured slices with antibodies against MAP2, neurofilament 200, synaptophysin, a synaptic vesicle protein and thus a marker of presynapses [31], and postsynaptic density protein 95 (PSD95), a postsynaptic scaffold protein and thus a marker of postsynapses [32]. The punctate structures immunopositive for these synapse markers were observed after 40 DIV (Fig. 1B, C). Furthermore, we examined the synaptic activity by using extracellular recording of fEPSP. Synaptic transmission was recorded at CA3-CA1 synapses in hippocampal slice cultures after 39 DIV (the results are shown in Fig. 8). These data indicate that synapses remained in cultured hippocampal slices for over 6weeks.
Next, we examined the spatial expression pattern of BACE1 in acute (0 DIV) and cultured (3–40 DIV) hippocampal slices by immunofluorescent staining with antibodies against BACE1. BACE1 expression in acute and cultured hippocampal slices accumulated at the stratum radiatum (Fig. 1D), similar to in vivo distribution [33]. Antibody specificity was confirmed by previous reports [34, 35]. These results suggested that cultured hippocampal slices conserved BACE1 expression, neural function, and organization forseveral weeks.
Chronological changes of BACE1 and synaptic protein expression
In organotypic cultures, conditions are changed every hour, just after plating on filter membrane cups or culture dishes. Previous reports showed that reorganization and maturation of synapses occurred in cultured hippocampal slices [23, 24]. To elucidate the time-dependent changes in synapse and AβPP processing, we evaluated the expression level of synaptic proteins, BACE1, and AβPP by immunoblotting assays for several weeks (Supplementary Figure 1). Immunoblotting signals prepared from cultured slices indicated corresponding molecular weights (approximately BACE1: 70 kDa; AβPP: 100 kDa; synaptophysin: 38 kDa; PSD95: 95 kDa; β-actin: 43 kDa, Fig. 2A-E).
Similarly to immunohistological analysis (Fig. 1B, C), immunoblotting analyses revealed that synapse marker proteins synaptophysin, PSD95, and GluA2/3, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, decreased from 1 to 4 DIV and increased after 7 DIV. In addition, our data indicated that expression levels of synaptophysin and PSD95 were stable after 20 DIV (Fig. 2H, I, and Supplementary Figure 1). In contrast, quantitative immunoblotting analyses suggested that expression levels of BACE1 and AβPP were not changed significantly after 7 DIV (Fig. 2F, G).Immature, mature and phosphorylated AβPP were detected in acute and cultured hippocampal slices (Supplementary Figure 2). Consistent with the previous studies [23–26, 28], these results suggested that 3–20 DIV were a critical period of synapse formation and maturation in hippocampal slice cultures. Furthermore, our data indicated that synapse conditions and expression of BACE1 and AβPP were stable after 20 DIV. In this study, we define the 3–18 DIV as the synaptic developing stage, and the 26 day after in vitro as the synaptic developedstage.
Chronological analysis of production of sAβPPβ and Aβ
For the continuous monitoring of the BACE1 activity, we measured BACE1 cleavage products sAβPPβ and Aβ40 in SCM. BACE1 cleaves AβPP at extracellular sites and generates soluble extracellular fragments: sAβPPβ and a membrane-bound carboxyl terminal fragment, AβPP-CTFβ. The AβPP-CTFβ is subsequently cleaved by γ-secretase to produce Aβ, released to extracellular SCM. To estimate BACE1 activity, we measured sAβPPβ and Aβ in SCM from cultured hippocampal slices with a two-site ELISA assay (see Materials and Methods). To quantify sAβPPβ and Aβ40 secretion levels, we collected SCM cultured hippocampal slices for 24 h after washing three times with 1 mL fresh SCM. Secretion of sAβPPβ was between 3 to 6 ng/mL (Fig. 3A), and secretion of Aβ40 was between 200 to 300 pg/mL during the monitoring period (Fig. 3B). Furthermore, secretion of Aβ42 was between 23 and 50 pg/mL for 24 h and showed a chronological change similar to Aβ40 in cultured hippocampal slices (data not shown). Production of sAβPPβ and Aβ from cultured rat hippocampal slices and ratio of Aβ to sAβPPβ were stable after 7 DIV (Fig. 3C).
Pharmacological manipulation of BACE1
AβPP is alternatively cleaved by the members of the α-secretase family or BACE. The α-secretase is considered to be a part of the non-amyloidogenic pathway in AβPP processing, as it precludes Aβ formation [36, 37]. To check enzyme dependencies on AβPP metabolism in our system, we investigated the effect of each secretase inhibitor on hippocampal slice cultures. We cultured hippocampal slices for 24 h with fresh SCM containing vehicle (DMSO) or inhibitors after washing three times with 1 mL fresh SCM (Fig. 4). In accordance with previous reports [38], application of BACE inhibitor reduced secretion of Aβ40 (Fig. 4B, D). AβPP is alternatively cleaved within the Aβ sequence by α-secretase, and application of the α-secretase inhibitor TAPI-1 increased secretion of Aβ40 (Fig. 4C, D). Because BACE1 enzymatic activities were observed throughout the culture period, we investigated the effect of BACE inhibitor during the developing or developed stage of the synapse (Fig. 5). During both stages, application of BACE inhibitor IV reduced secretion of Aβ40 (Fig. 5A, B) and sAβPP (Fig. 5C, D).
To evaluate the cytotoxicity of BACE inhibitor treatment, we used PI staining assays. Since live cells are not permeable to PI, PI fluorescence intensity can be used as an index for total neuronal degeneration. In contrast to kainic acid-induced cell death, long-term treatment with BACE inhibitor failed to affect survival of cultured hippocampal neurons (Fig. 6 and Supplementary Figure 3). These results indicated that alternative AβPP processing occurred and we could control AβPP cleavage in cultured hippocampal slices without toxic effects.
BACE1 activity is known to be important for synapse formation and maturation in the hippocampus [33]. Thus, we investigated the effect of continuous BACE1 inhibition on synapses in cultured hippocampal slices. When BACE inhibitor was applied during the period of synaptogenesis and maturation (3.5–17.5 DIV, cf. Fig. 2), PSD95 and GluA2/3 decreased (Fig. 7A-F). Conversely, application of BACE inhibitor after the period of synaptogenesis and maturation (26–42 DIV) did not affect pre- and post-synapse (Fig. 7G-L). In both periods, the addition of BACE inhibitor IV to SCM suppressed β cleavage of AβPP and accumulated mature AβPP (Fig. 7E, K). Furthermore, immunofluorescent staining analysis revealed that PSD95, but not synaptophysin, decreased in each punctate (Supplementary Figure 4, PSD95; 66.9±31.9%, synaptophysin; 114.4±15.9%). In concordance with change of protein level of GluA2/3, electrophysiological analysis indicated that application of BACE inhibitor during the developing stage decreased synaptic strength in the CA3-CA1 pathway (Fig. 8). These data suggested the importance of BACE1 activity in synaptogenesis and maturation; however, it has less function in matured synapses.
DISCUSSION
In this report, we investigated the β cleavage of AβPP and effect of BACE1 inhibition on synapses using organotypic hippocampal slice cultures, with advantages over in vivo and in vitro platforms [20]. These preparations preserved tissue structures and neural circuits such as DG-CA3-CA1 in the hippocampus. We have previously suggested that synaptic transmission and plasticity can be monitored in cultured hippocampal slices [25, 29]. In this report, we characterized cultured hippocampal slices, because basic information is essential for the use of culture preparation as an assay platform. First, we investigated the tissue architecture of cultured hippocampal slices and the structure of neurons. We showed that the arrangement of pyramidal neurons and the structure of synapses were maintained inhippocampal slices for several weeks (Fig. 1A-C). Our preliminary immunostaining analyses indicated that glial cells also remained in cultured slices (data not shown). Similar to the in vivo distribution, BACE1 expression accumulated at the stratum radiatum in cultured hippocampal slices (Fig. 1D). Immunoblotting and immunohistostaining analyses revealed that the synapse marker proteins synaptophysin, PSD95, and glutamate receptor GluA2/3 decreased from 1 to 4 DIV, and increased after 7 DIV (Fig. 2, Supplementary Figure 1). This change may suggest abolition and reorganization of synapses [23, 28]. Furthermore, our data indicated that synapse conditions may be stable after 21 DIV. Quantitative immunoblotting analyses suggested that expression levels of BACE1 and AβPP were not changed significantly after 7 DIV. Immunoblotting analysis indicated that the molecular weight of BACE1 changed slightly, which may represent the effect of the BACE1 maturation process. Newly synthesized BACE1 is cleaved at its prodomain before transport to the trans-Golgi network [39]. These results indicated that slice culture may be suitable for continuous ex vivo analysis of BACE1 and synapses.
Cleavage of AβPP by BACE1 produces sAβPPβ and CTFβ, and CTFβ is subsequently cleaved by γ-secretase to produce Aβ. To estimate BACE1 activity, we measured sAβPPβ and Aβ40 secreted from hippocampal slices using a two-site ELISA assay. In culture medium, four cultured hippocampal slices secreted 3–6 ng sAβPPβ and 200–400 pg Aβ40 for 24 h (Fig. 3). These data indicated that 30–60 pg sAβPPβ and 2.0–3.0 pg Aβ40 were secreted by a cultured hippocampal slice in 1 h. The apparent molecular weights of mature sAβPPβ and Aβ40 are 65.7 kDa and 4.3 kDa, respectively. Further calculation suggests that the molar ratio of Aβ40 to sAβPPβ was 0.6–1.0. In accordance with previous reports [38], application of BACE inhibitor reduced secretion of Aβ40 and sAβPPβ, and application of α-secretase, TAPI-1 increased secretion of Aβ40 (Figs. 4, 5). To determine the effect of BACE inhibitors on neurons in slices, we examined neural cell survival using PI staining (Supplementary Figure 3). When BACE inhibitor was applied for 2 weeks (3.5–17.5 or 26–42 DIV), the expression level of βIII tubulin did not decrease (Fig. 7). These data suggest that BACE inhibitor treatment did not affect neuronal survival in mature hippocampal slice culture. Many reports suggest functions of Aβ and sAβPPβ, including neurodegeneration, neuroprotection, learning, and memory [40]. In addition, recent studies showed that AβPP is processed by other proteases, δ- and η-secretase, and its products inhibit neural activity and memory [41, 42]. In concordance with previous studies, mature AβPP seems to be more impacted than immature AβPP by the treatment of BACE inhibitor (Fig. 7A). Our system will be an excellent model to elucidate the role of these secretases and their products.
During synapse development and maturation, synaptic activity either stabilizes or eliminates synapses, and the selected synapses finally establish appropriate synaptic connections [43, 44]. BACE1 activity itself is modulated by synaptic activity and has an effect on synapse formation and plasticity [15, 45]. In previous studies, BACE1 knockout mice showed synaptic dysfunction and psychiatric phenotypes similar to neurodevelopmental disorders [33, 46]. The effect of BACE1 deletion on matured synapses remained to be elucidated. We accordingly examined synapse protein in cultured slices to determine the impact of BACE1 inhibition on synapses. To dissect BACE1 function in synaptic developing or developed synapses, we used the BACE inhibitor in a restricted period. During the period of synapse formation and maturation (3.5–17.5 DIV), pharmacological inhibition of BACE1 activity decreased the levels of PSD95, a postsynaptic structure protein, and GluA2/3, AMPA receptor subunit, but did not change synaptophysin, a synaptic vesicle membrane protein (Fig. 7). After synaptic maturation (26–42 DIV), BACE1 inhibition did not affect the levels of synaptic proteins. Increased full length AβPP (FL AβPP) supports the efficacy of BACE1 inhibition (Fig. 7). Furthermore, application of BACE inhibitor during the developing stage decreased synaptic strength in the CA3-CA1 pathway (Fig. 8). These results suggest that BACE inhibitor impedes maturation of the synaptic structure and transmission. A recent study showed that synaptic dysfunctions seen in BACE1 knockout mice are specifically postsynaptic [46]. Furthermore, long-term pharmacological inhibition of BACE1 did not impact the number of spines but did impair synaptic plasticity in 2-3-month-old mice [47]. Our results and previous reports indicate that BACE1 activity is important for synaptogenesis and maturation.
Taken together, our results suggest that cultured hippocampal slices are useful tools for understanding physiological functions of BACE1 and AβPP processing. This report is the first step toward ex vivo continuous analysis of AβPP and BACE1.
Footnotes
ACKNOWLEDGMENTS
This work was supported by JSPS KAKENHI Grant Number 26460707 (to Y.K.), and 16H04667, 3300128, 26670127 (to T.S.), by the Strategic Research Program for Brain Sciences (Development of biomarker candidates for social behavior) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from MEXT, MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011–2015. This study was also supported in part by a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from MEXT. This work was supported by a grants-in-aid of The Fugaku Trust for Medicinal Research (to T.S.), and a grants-in-aid of The Takeda Science Foundation (to Y.K.).
